$1.42
00.00%
Pre-Market: 6:19 PM EDT
15 minutes delayed
Comments
Loading...
Atossa Therapeutics (ATOS) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestAtossa Therapeutics (NASDAQ:ATOS) Stock Quotes, Forecast and News Summary
Atossa Therapeutics Stock (NASDAQ: ATOS) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 0 / 999.53K |
| Day Range | - - - |
| 52 Wk Range | 0.62 - 2.31 |
| Market Cap | $178.58M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 53 |
| Short Interest | 10.26% |
| Days to Cover | 23.71 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Atossa Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary innovat...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Atossa Therapeutics (ATOS) stock?
You can purchase shares of Atossa Therapeutics (NASDAQ:ATOS) through any online brokerage.
Who are Atossa Therapeutics (ATOS) competitors?
Other companies in Atossa Therapeutics’s space includes: Macrogenics (NASDAQ:MGNX), Molecular Partners (NASDAQ:MOLN), Innate Pharma (NASDAQ:IPHA), Skye Bioscience (NASDAQ:SKYE) and Cabaletta Bio (NASDAQ:CABA).
What is the forecast, or price target, for Atossa Therapeutics (ATOS) stock?
Atossa Therapeutics has a consensus price target of $6.25.
What is the current price for Atossa Therapeutics (ATOS)?
The stock price for Atossa Therapeutics (NASDAQ: ATOS) is $1.42 last updated September 18, 2024 at 6:19 PM EDT.
Does Atossa Therapeutics (ATOS) pay a dividend?
There are no upcoming dividends for Atossa Therapeutics.
When is Atossa Therapeutics (NASDAQ:ATOS) reporting earnings?
Atossa Therapeutics’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
Is Atossa Therapeutics (ATOS) going to split?
There is no upcoming split for Atossa Therapeutics.
What sector and industry does Atossa Therapeutics (ATOS) operate in?
Atossa Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.